BGF World Healthscience Fund

Equity

BGF World Healthscience Fund

  • NAV as of 19-Feb-19 USD 11.17
    52 WK: 9.52 - 11.45
  • 1 Day NAV Change as of 19-Feb-19 -0.01 (-0.09%)

Overview

Investment Approach

The Fund aims to maximise the return on your investment through a combination of capital growth and income on the Fund’s assets. The Fund invests globally at least 70% of its total assets in the shares of companies the main business of which is in healthcare, pharmaceuticals, medical technology and supplies and the development of biotechnology.

Important Information: Capital at Risk. All financial investments involve an element of risk. Therefore, the value of your investment and the income from it will vary and your initial investment amount cannot be guaranteed.

Show Fewer
Loading

Performance

Performance

  • Returns

Returns not available as there is less than one year’s performance data.
Returns not available as there is less than one year’s performance data.
Returns not available as there is less than one year’s performance data.

The figures shown relate to past performance. Past performance is not a reliable indicator of future results and should not be the sole factor of consideration when selecting a product or strategy.

Share Class and Benchmark performance displayed in USD, hedged fund benchmark performance is displayed in USD.

Performance is shown on a Net Asset Value (NAV) basis, with gross income reinvested where applicable. The return of your investment may increase or decrease as a result of currency fluctuations if your investment is made in a currency other than that used in the past performance calculation. Source: Blackrock

Distributions

Record Date Ex-Date Payable Date
View full table
Record Date Ex-Date Payable Date Total Distribution

Key Facts

Key Facts

Size of Fund (Millions) as of 19-Feb-19 USD 4,053.769
12m Trailing Yield The yield an investor would have received if they had held the fund over the last twelve months assuming the most recent NAV. The 12-Month yield is calculated by assuming any income distributions over the past twelve months and dividing by the sum of the most recent NAV and any capital gain distributions made over the past twelve months. as of 31-Jan-19 0.29
Number of Holdings The number of holdings in the fund excluding cash positions and derivatives exposures. Derivatives are contracts used by the fund to gain exposure to an investment without buying it directly. They can be used in a number of ways. For example a 'currency forward' derivative contract can be used to 'hedge' or aim to mitigate the effects of changes in exchange rates. as of 31-Jan-19 105
Base Currency USD
Fund Launch Date 06-Apr-01
Inception Date 28-Feb-18
Asset Class Equity
Morningstar Category Sector Equity Healthcare
Benchmark Index MSCI WRLD HealthCare ND
Domicile Luxembourg
Regulatory Structure UCITS
Management Company BlackRock (Luxembourg) S.A.
Ongoing Charges Figures Ongoing Charges Figure (OCF)- this is a measure of the total costs associated with managing and operating an investment fund. These costs consist primarily of management fees and other expenses such as trustee, custody, transaction and registration fees and other operating expenses. The total cost for the fund is divided by the fund’s total assets and expressed as a percentage which represents the OCF. 1.07%
ISIN LU1728553774
Bloomberg Ticker BGWHD4U
Initial Charge 5.00%
Performance Fee 0.00%
SEDOL BG0QCX6
Bloomberg Benchmark Ticker -
Dealing Settlement Trade Date + 3 days
Dealing Frequency Daily, forward pricing basis
Minimum Initial Investment USD 100000
Minimum Subsequent Investment USD 1000
Use of Income Distributing

Risk Indicator

Risk Indicator

1
2
3
4
5
6
7
Low Risk High Risk
Typically low rewards Typically high rewards

Ratings

Holdings

Holdings

as of 31-Jan-19
Name Weight (%)
UNITEDHEALTH GROUP INC 5.38
PFIZER INC 5.11
ABBOTT LABORATORIES 5.08
BOSTON SCIENTIFIC CORP 4.41
ROCHE HOLDING PAR AG 3.89
Name Weight (%)
NOVARTIS AG 3.50
MERCK & CO INC 3.31
ASTRAZENECA PLC 3.28
SANOFI SA 3.02
MEDTRONIC PLC 2.73
Holdings subject to change

Pricing & Exchange

Investor Class Currency Distribution Frequency NAV NAV Amount Change NAV % Change 52wk High 52wk Low Bid Price ISIN Offer Price TIS
Class D4 USD Annual 11.17 -0.01 -0.09 11.45 9.52 - LU1728553774 - -
Class E2 USD None 41.03 -0.03 -0.07 42.26 35.24 - LU0122380701 - -
Class A2 Hedged CNH None 126.21 -0.07 -0.06 129.46 107.28 - LU1254117382 - -
Class A2 Hedged EUR None 10.76 -0.01 -0.09 11.22 9.65 - LU1822774284 - -
Class A2 Hedged AUD None 15.63 -0.01 -0.06 16.15 13.47 - LU1023059063 - -
Class D2 EUR None 43.12 -0.02 -0.05 43.38 33.72 - LU0827889485 - -
Class E2 EUR None 36.25 -0.01 -0.03 36.56 28.66 - LU0171309270 - -
Class A2 Hedged HKD None 155.06 -0.10 -0.06 160.06 133.83 - LU1061106388 - -
Class A2 Hedged SGD None 15.59 -0.01 -0.06 16.11 13.47 - LU1057294990 - -
Class C2 USD None 36.15 -0.02 -0.06 37.33 31.25 - LU0147404148 - -
Class C2 EUR None 31.93 -0.02 -0.06 32.26 25.41 - LU0331289677 - -
Class X2 USD None 52.78 -0.03 -0.06 53.89 44.44 - LU0462856898 - -
Class A2 EUR None 39.58 -0.02 -0.05 39.88 31.16 - LU0171307068 - -
Class D2 USD None 48.81 -0.03 -0.06 50.03 41.46 - LU0329593007 - -
Class A2 USD None 44.81 -0.03 -0.07 46.06 38.32 - LU0122379950 - -

Portfolio Managers

Portfolio Managers

Erin Xie
Erin Xie

Literature

Literature